Altus Wealth Management LLC grew its holdings in The Procter & Gamble Company (NYSE:PG - Free Report) by 7.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 57,033 shares of the company's stock after purchasing an additional 4,109 shares during the period. Procter & Gamble makes up 4.3% of Altus Wealth Management LLC's investment portfolio, making the stock its 7th largest position. Altus Wealth Management LLC's holdings in Procter & Gamble were worth $9,562,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. RPg Family Wealth Advisory LLC acquired a new position in shares of Procter & Gamble during the third quarter worth about $33,000. Costello Asset Management INC raised its stake in Procter & Gamble by 2,142.9% during the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company's stock worth $54,000 after acquiring an additional 300 shares in the last quarter. Mendota Financial Group LLC boosted its position in shares of Procter & Gamble by 58.0% in the 4th quarter. Mendota Financial Group LLC now owns 376 shares of the company's stock valued at $63,000 after purchasing an additional 138 shares during the period. Itau Unibanco Holding S.A. grew its stake in Procter & Gamble by 138.7% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 401 shares of the company's stock worth $69,000 after buying an additional 233 shares during the last quarter. Finally, Hara Capital LLC acquired a new position in Procter & Gamble during the third quarter worth approximately $70,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the sale, the insider now directly owns 11,595 shares in the company, valued at $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary A. Coombe sold 47,847 shares of the firm's stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 151,097 shares of company stock valued at $25,635,076 over the last three months. Company insiders own 0.18% of the company's stock.
Analysts Set New Price Targets
A number of brokerages recently weighed in on PG. Morgan Stanley increased their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a research note on Monday, October 21st. Stifel Nicolaus raised their price target on Procter & Gamble from $161.00 to $165.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. UBS Group reduced their price objective on Procter & Gamble from $196.00 to $189.00 and set a "buy" rating for the company in a research note on Thursday, January 16th. Evercore ISI increased their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research report on Monday, October 21st. Finally, Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $176.00 to $180.00 and gave the company an "overweight" rating in a research note on Thursday, January 23rd. Eight equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $180.53.
Check Out Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Stock Performance
Procter & Gamble stock traded up $1.20 during mid-day trading on Thursday, reaching $167.43. The company's stock had a trading volume of 4,132,297 shares, compared to its average volume of 7,479,630. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.49. The Procter & Gamble Company has a twelve month low of $153.52 and a twelve month high of $180.43. The business has a 50 day moving average price of $168.65 and a 200-day moving average price of $169.39. The firm has a market cap of $394.31 billion, a price-to-earnings ratio of 26.66, a PEG ratio of 3.69 and a beta of 0.45.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 32.88%. The business had revenue of $21.88 billion during the quarter, compared to the consensus estimate of $21.66 billion. During the same quarter in the prior year, the firm earned $1.84 EPS. The company's revenue for the quarter was up 2.1% compared to the same quarter last year. Sell-side analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be paid a dividend of $1.0065 per share. The ex-dividend date is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a yield of 2.40%. Procter & Gamble's payout ratio is currently 64.17%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.